Pfm Health Sciences, LP Cullinan Oncology, Inc. Transaction History

Pfm Health Sciences, LP

  • $1.19 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$16.03 - $20.86 $1.82 Million - $2.36 Million
-113,226 Reduced 38.25%
182,810 $3.06 Million
Q2 2024

Aug 14, 2024
BUY
$15.63 - $29.35 $626,278 - $1.18 Million
40,069 Added 15.65%
296,036 $5.16 Million
Q1 2024

May 14, 2024
BUY
$10.17 - $19.02 $2.6 Million - $4.87 Million
255,967 New
255,967 $4.36 Million

About Cullinan Oncology, Inc.

CGEM Quotes by TradingView
  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $390M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email